Literature DB >> 9267482

Frequency of thyroid carcinoma in a recent series of 539 consecutive thyroidectomies for multinodular goiter.

M R Pelizzo1, P Bernante, A Toniato, A Fassina.   

Abstract

AIMS AND
BACKGROUND: The aim of the study was to analyze the frequency of thyroid carcinoma in a consecutive series of 539 thyroidectomies for multinodular goiter (MNG) and to assess the influence of sex and age as cancer risk factors.
METHODS: In a 2-year period, 539 patients underwent subtotal or total thyroidectomy for MNG at the institute of General Surgery, University of Padova, Padova, Italy: 455 were females and 84 males (F/M = 5.5/1); mean age was 46 years (min. 17, max 78). Only 17 patients (3.1%) (16 females and 1 male) were aged 21 years or less.
RESULTS: A malignancy was found in 41 patients: 38 females and 3 males; 39 older and 2 younger than 21 years. The frequency of cancer in MNG was 7.6%: 8.3% in females and 3.6% in males; 7.5% in patients older than 21 and 11.7% under 21 years.
CONCLUSIONS: The combination of MNG and carcinoma should always be carefully considered but not overemphasized, and the policy of surgically treating all patients with MNG is not justified. Sex and age cannot be considered as factors of a higher risk of cancer.

Entities:  

Mesh:

Year:  1997        PMID: 9267482     DOI: 10.1177/030089169708300305

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  14 in total

1.  A Conservative Approach Is Reasonable in Patients with Non-Toxic Goitre: Results from an Observational Study during 30 Years.

Authors:  Johannes Järhult; Ramtin Vedad
Journal:  Eur Thyroid J       Date:  2014-10-15

Review 2.  Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters.

Authors:  M Knobel
Journal:  J Endocrinol Invest       Date:  2015-09-21       Impact factor: 4.256

3.  Complications in thyroid resurgery: a single institutional experience on 233 patients from a whole series of 4,752 homogeneously treated patients.

Authors:  M R Pelizzo; M Variolo; C Bernardi; M Izuzquiza; A Piotto; G Grassetto; P M Colletti; I Merante Boschin; D Rubello
Journal:  Endocrine       Date:  2014-03-11       Impact factor: 3.633

4.  Is fine-needle aspiration (FNA) of multiple thyroid nodules justified?

Authors:  Julieta E Barroeta; Hongling Wang; Natsuko Shiina; Prabodh K Gupta; Virginia A Livolsi; Zubair W Baloch
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

5.  Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series.

Authors:  Patrícia Sabino de Matos; Ana Paula C Ferreira; Laura S Ward
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

6.  Targeted Next-Generation Sequencing Analysis of a Pendred Syndrome-Associated Thyroid Carcinoma.

Authors:  Guo-Xia Tong; Qing Chang; Diane Hamele-Bena; John Carew; Richard S Hoffman; Marina N Nikiforova; Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

7.  Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.

Authors:  Hang Yu; Xiaomei Huang; Xiaosun Liu; Hailong Jin; Ge'er Zhang; Qing Zhang; Jiren Yu
Journal:  Endocrine       Date:  2012-12-22       Impact factor: 3.633

8.  An Indian Tertiary Care Hospital Scenario of Papillary Carcinoma of Thyroid.

Authors:  Ponnuswamy Karkuzhali; Muthureddy Yogambal; Manoj Kumar
Journal:  J Clin Diagn Res       Date:  2017-06-01

9.  Papillary and Medullary Thyroid Carcinomas Presenting as Collision Tumors: A Case Series of 21 Cases at a Tertiary Care Cancer Center.

Authors:  Ann Thomas; Neha Mittal; Swapnil U Rane; Munita Bal; Asawari Patil; Suman Kumar Ankathi; Richa Vaish
Journal:  Head Neck Pathol       Date:  2021-04-11

10.  Serum 8-OHdG and HIF-1α levels: do they affect the development of malignancy in patients with hypoactive thyroid nodules?

Authors:  Harman Ece; Erdogan Mehmet; Biray Avci Cigir; Dodurga Yavuz; Karadeniz Muammer; Gunduz Cumhur; Harman Mustafa; Cetinkalp Sevki; Saygılı Fusun; Ozgen Ahmet Gokhan
Journal:  Contemp Oncol (Pozn)       Date:  2013-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.